These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 15960988)

  • 21. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor.
    Wood MD; Boyfield I; Nash DJ; Jewitt FR; Avenell KY; Riley GJ
    Eur J Pharmacol; 2000 Oct; 407(1-2):47-51. PubMed ID: 11050289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.
    Chen YC; Choi JK; Andersen SL; Rosen BR; Jenkins BG
    Psychopharmacology (Berl); 2005 Aug; 180(4):705-15. PubMed ID: 15536545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists.
    Xu M; Koeltzow TE; Cooper DC; Tonegawa S; White FJ
    Synapse; 1999 Mar; 31(3):210-5. PubMed ID: 10029239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
    Spealman RD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D3 receptor antagonists: a patent review (2007 - 2012).
    Micheli F; Heidbreder C
    Expert Opin Ther Pat; 2013 Mar; 23(3):363-81. PubMed ID: 23282131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional role of dopamine D3 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.
    Collins GT; Newman AH; Grundt P; Rice KC; Husbands SM; Chauvignac C; Chen J; Wang S; Woods JH
    Psychopharmacology (Berl); 2007 Aug; 193(2):159-70. PubMed ID: 17393143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
    Filip M; Papla I; Czepiel K
    Pol J Pharmacol; 2002; 54(6):687-91. PubMed ID: 12866725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a functional role of the dopamine D3 receptors in the cerebellum.
    Barik S; de Beaurepaire R
    Brain Res; 1996 Oct; 737(1-2):347-50. PubMed ID: 8930390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    Wicke K; Garcia-Ladona J
    Eur J Pharmacol; 2001 Jul; 424(2):85-90. PubMed ID: 11476753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
    Malik P; Andersen MB; Peacock L
    Pharmacol Biochem Behav; 2004 Aug; 78(4):805-10. PubMed ID: 15301939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the development of dopamine D(3) receptor agonists and antagonists.
    Crider AM; Scheideler MA
    Mini Rev Med Chem; 2001 May; 1(1):89-99. PubMed ID: 12369994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
    Cook CD; Beardsley PM
    Pharmacol Biochem Behav; 2003 May; 75(2):363-71. PubMed ID: 12873628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The D3 dopamine receptor in cellular and organismal function.
    Shafer RA; Levant B
    Psychopharmacology (Berl); 1998 Jan; 135(1):1-16. PubMed ID: 9489928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.